A Randomized Patient Preference Trial on Heat-sensitive Moxibustion for Primary Hypertension in Community

• Status: Active, not recruiting
• Trial end date: 2021-12-31
• Target enrollment: 0
• Participant gender: All

Summary

Heat-sensitive moxibustion, an important mean of external therapy of traditional Chinese medicine, has unique advantages in treating various chronic diseases than common moxibustion. This study aims to evaluate the efficacy, safety, and cost-effectiveness of heat-sensitive moxibustion for primary hypertension under community self-management setting using a multicenter, pragmatic, randomized controlled trial design with patient-preference arms.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Jiangxi University of Traditional Chinese Medicine
• Treatments: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensinogen; Antihypertensive Agents; Calcium; Calcium Channel Blockers; Calcium, Dietary; Giapreza

Criteria

Inclusion Criteria:

1. Diagnosed with essential hypertension, i.e., systolic blood pressure ≥ 140mmHg and/or diastolic blood pressure ≥ 90 mmHg, with a course more than 6 months.

2. Ages: 18-80 years;

3. The original antihypertensive drugs are calcium channel blockers and/or angiotensin II receptor blockers.

4. Did not receive acupoint stimulation therapies for hypertension in the last month.

5. Patients in the heat-sensitive moxibustion groups need to develop at least one type of moxibustion sensation around the following acupoints: Yongquan, Baihui, Shenque, Quchi, Zusanli, Hegu, Taichong and Dazhui.

6. Consent to sign an informed consent form

Exclusion Criteria:

1. Systolic blood pressure ≥ 180mmHg and/or diastolic blood pressure ≥ 110mmHg after taking antihypertensive drugs;

2. Secondary hypertension.

3. Pregnancy and lactation;

4. Allergic to moxibustion devices, moxa smoke or Artemisia argyi.

5. Complicated with severe diseases that are not recommended for heat-sensitive moxibustion, such as acute cerebral hemorrhage, hypertensive crisis, sensory disturbances, serious mental diseases, etc.